Measles and mumps, two forgotten diseases, reveal an unfortunate comeback. In a free webinar, Oliver Sendscheid, PhD, Scientific Director at EUROIMMUN US, and Rolando Pajon, PhD, Lead Scientist for Vaccine and Novel Immunotherapeutic Laboratory Solutions at COVANCE CLS address the current epidemiologic status of measles and mumps, challenges and solutions in serological testing, perspectives in vaccine […]
Since the last large Zika fever epidemic in Brazil 2015/2016, during which an association of the infectious disease with severe neurological syndromes was identified (Guillain-Barré syndrome in adults, congenital neurological damages in newborns), the demand for reliable diagnostic tests has increased extremely. With the new PCR-based direct detection, EUROIMMUN complements the existing range of serological
EUROIMMUN now offers a new ELISA for the detection of IgA antibodies for the diagnosis of Zika infections. But why is this necessary? Determination of anti-Zika virus IgA may help in the diagnosis of acute Zika virus infections if specific IgM antibodies are not measurable. Primary and secondary immune response in Zika virus infections Usually, IgM antibodies
A few days ago, Prof Dr Ute Mackenstedt from the University of Hohenheim, an expert in the research of ticks, together with Dr Gerhard Dobler from the reference laboratory for tick-borne encephalitis (TBE) and Dr Rainer Oehme from the Baden-Württemberg Health Authority, reported on two novel ways by which TBE viruses can be transmitted to
Press release Luebeck, April 6th 2017 Today EUROIMMUN and Roche announced that they have entered into an option agreement under which Roche gains access to intellectual property in the field of Zika virus immunodiagnostics assigned to EUROIMMUN. In January 2016, EUROIMMUN became the first company in the world to launch antibody tests that are capable
